| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 25.49▼ | 25.61▼ | 25.62▼ | 25.70▼ | 25.86▼ |
| MA10 | 25.46▼ | 25.55▼ | 25.56▼ | 25.76▼ | 26.48▼ |
| MA20 | 25.56▼ | 25.81▼ | 25.92▼ | 25.51▼ | 29.25▼ |
| MA50 | 25.92▼ | 25.92▼ | 25.62▼ | 27.30▼ | 31.63▼ |
| MA100 | 25.67▼ | 25.49▼ | 26.14▼ | 29.68▼ | 27.39▼ |
| MA200 | 25.77▼ | 26.62▼ | 27.89▼ | 31.46▼ | 23.08▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.026▼ | -0.025▼ | -0.054▼ | 0.102▲ | -0.480▼ |
| RSI | 43.956▼ | 43.330▼ | 43.163▼ | 43.185▼ | 40.017▼ |
| STOCH | 55.117 | 50.062 | 42.982 | 53.806 | 23.235 |
| WILL %R | -65.926 | -74.515 | -74.515 | -45.547 | -81.956▼ |
| CCI | -77.335 | -121.917▼ | -131.009▼ | -32.146 | -77.557 |
| ▲ GAP | $ALBO Open Gap Up %2 | Set Alert |
|
Sunday, December 09, 2018 11:03 PM
Albireo Pharma (NASDAQ:ALBO) was upgraded by stock analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research note issued to investors on Saturday. Several other brokerages ha...
|
|
Tuesday, December 04, 2018 09:00 PM
Wall Street analysts expect Albireo Pharma Inc (NASDAQ:ALBO) to post $1.94 million in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates fo...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/12/18 | 26.06 | 26.08 | 24.73 | 25.19 | 19,615 |
| 10/12/18 | 25.75 | 26.6187 | 24.84 | 25.35 | 109,739 |
| 07/12/18 | 26.30 | 26.73 | 24.97 | 25.49 | 49,883 |
| 06/12/18 | 25.99 | 26.41 | 25.03 | 26.30 | 27,860 |
| 04/12/18 | 26.37 | 26.90 | 25.48 | 26.17 | 36,440 |
| 03/12/18 | 26.84 | 26.98 | 26.115 | 26.27 | 37,798 |
| 30/11/18 | 25.83 | 26.84 | 25.0949 | 26.45 | 30,234 |
| 29/11/18 | 25.33 | 26.01 | 25.13 | 25.74 | 20,744 |
| 28/11/18 | 25.25 | 25.67 | 24.62 | 25.46 | 22,842 |
| 27/11/18 | 25.85 | 26.32 | 24.86 | 25.20 | 38,487 |
|
|
||||
|
|
||||
|
|
||||
|
|